| Name | Mesa |
|---|---|
| Organization Name | Mesa, Llc |
| Location | 2603 Bloomington Ave, Minneapolis, Minnesota 55407 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (612) 501-5009 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Patients treated for their prolonged seizures with the sedative propofol may be at high risk for complications and even death. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that the use of propofol as an antiepileptic agent in patients with refractory status epilepticus (RSE), prolonged seizures that do not respond to initial treatment, was associated with significant mortality and morbidity.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a multicenter Phase 2 clinical trial led by a Dana-Farber Cancer Institute researcher.
Scientists are reporting development and successful testing of a rapid and accurate test to tell the difference between bacterial and viral infections. Those common afflictions often have similar symptoms but vastly different treatments - antibiotics work for bacterial infections but not for viruses. The report appears in ACS' journal Analytical Chemistry.
› Verified 5 days ago
| NPI Number | 1215554225 |
| Organization Name | MESA, LLC |
| Doing Business As | MESA |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2603 Bloomington Ave, Minneapolis, MN 55407 |
| Phone Number | 612-501-5009 |
News Archive
Patients treated for their prolonged seizures with the sedative propofol may be at high risk for complications and even death. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that the use of propofol as an antiepileptic agent in patients with refractory status epilepticus (RSE), prolonged seizures that do not respond to initial treatment, was associated with significant mortality and morbidity.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a multicenter Phase 2 clinical trial led by a Dana-Farber Cancer Institute researcher.
Scientists are reporting development and successful testing of a rapid and accurate test to tell the difference between bacterial and viral infections. Those common afflictions often have similar symptoms but vastly different treatments - antibiotics work for bacterial infections but not for viruses. The report appears in ACS' journal Analytical Chemistry.
› Verified 5 days ago
News Archive
Patients treated for their prolonged seizures with the sedative propofol may be at high risk for complications and even death. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that the use of propofol as an antiepileptic agent in patients with refractory status epilepticus (RSE), prolonged seizures that do not respond to initial treatment, was associated with significant mortality and morbidity.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a multicenter Phase 2 clinical trial led by a Dana-Farber Cancer Institute researcher.
Scientists are reporting development and successful testing of a rapid and accurate test to tell the difference between bacterial and viral infections. Those common afflictions often have similar symptoms but vastly different treatments - antibiotics work for bacterial infections but not for viruses. The report appears in ACS' journal Analytical Chemistry.
› Verified 5 days ago
Mesa Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2603 Bloomington Ave, Minneapolis, Minnesota 55407 Phone: (612) 501-5009 | |
Alina Health System Type: Community/Retail Pharmacy Location: 913 E 28th Street, Minneapolis, Minnesota 55407 Phone: (612) 863-5370 | |
Allina Health System Type: Clinic Pharmacy Location: 920 E 28th St, Minneapolis, Minnesota 55407 Phone: (612) 775-3100 | |
Cvs Pharmacy #07172 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2001 Nicollet Ave, Minneapolis, Minnesota 55404 Phone: (612) 872-2656 | |
Cvs Pharmacy #05996 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3655 Central Ave Ne, Minneapolis, Minnesota 55418 Phone: (612) 789-2460 |